Cargando…

Synthetic Osmotic Dilators for Pre-Induction Cervical Ripening – an Evidence-Based Review

Mechanical methods have gained growing interest for pre-induction cervical ripening in women with an unripe cervix, since they have a better safety profile compared to prostaglandins. Balloon catheters have been the gold standard method for decades, while there was a lack of data on synthetic osmoti...

Descripción completa

Detalles Bibliográficos
Autores principales: Rath, Werner, Kummer, Julia, Königbauer, Josefine T., Hellmeyer, Lars, Stelzl, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689108/
https://www.ncbi.nlm.nih.gov/pubmed/38046527
http://dx.doi.org/10.1055/a-2103-8329
_version_ 1785152302424784896
author Rath, Werner
Kummer, Julia
Königbauer, Josefine T.
Hellmeyer, Lars
Stelzl, Patrick
author_facet Rath, Werner
Kummer, Julia
Königbauer, Josefine T.
Hellmeyer, Lars
Stelzl, Patrick
author_sort Rath, Werner
collection PubMed
description Mechanical methods have gained growing interest for pre-induction cervical ripening in women with an unripe cervix, since they have a better safety profile compared to prostaglandins. Balloon catheters have been the gold standard method for decades, while there was a lack of data on synthetic osmotic cervical dilators. Not until 2015, when Dilapan-S was approved by the Food and Drug Administration (FDA) for induction of labor, numerous studies have been published on the use of Dilapan-S in this field. The rate of vaginal deliveries associated with the use of Dilapan-S ranges from 61.6 to 81.7%, and no serious complications needing further interventions have been reported to this date. Dilapan-S was shown to be as effective as the Foley balloon catheter as well as the 10 mg PGE (2) vaginal insert and orally applied misoprostol (25 µg every 2 hours) in achieving vaginal delivery, but patient’s satisfaction during the cervical ripening process was significantly higher compared to the other methods and the rate of uterine hyperstimulation was significantly lower compared to prostaglandins (PGs). Minor complications (e.g. vaginal bleeding) associated with the use of Dilapan-S were < 2%, and maternal infectious morbidity was not higher compared to Foley balloon and vaginal PGE (2) or misoprostol. Due to these beneficial properties Dilapan-S might be an ideal option for outpatient cervical ripening, as shown in a recent randomized clinical trial comparing inpatient to outpatient cervical ripening. Furthermore, according to the manufacturers’ product information, Dilapan-S is the only cervical ripening method that is not contraindicated for induction of labor in women with a previous cesarean section. Upcoming guidelines should consider synthetic osmotic cervical dilators as an effective and safe method for cervical ripening/induction of labor acknowledging that more evidence-based data are mandatory, particularly in patients with a previous cesarean section.
format Online
Article
Text
id pubmed-10689108
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-106891082023-12-01 Synthetic Osmotic Dilators for Pre-Induction Cervical Ripening – an Evidence-Based Review Rath, Werner Kummer, Julia Königbauer, Josefine T. Hellmeyer, Lars Stelzl, Patrick Geburtshilfe Frauenheilkd Mechanical methods have gained growing interest for pre-induction cervical ripening in women with an unripe cervix, since they have a better safety profile compared to prostaglandins. Balloon catheters have been the gold standard method for decades, while there was a lack of data on synthetic osmotic cervical dilators. Not until 2015, when Dilapan-S was approved by the Food and Drug Administration (FDA) for induction of labor, numerous studies have been published on the use of Dilapan-S in this field. The rate of vaginal deliveries associated with the use of Dilapan-S ranges from 61.6 to 81.7%, and no serious complications needing further interventions have been reported to this date. Dilapan-S was shown to be as effective as the Foley balloon catheter as well as the 10 mg PGE (2) vaginal insert and orally applied misoprostol (25 µg every 2 hours) in achieving vaginal delivery, but patient’s satisfaction during the cervical ripening process was significantly higher compared to the other methods and the rate of uterine hyperstimulation was significantly lower compared to prostaglandins (PGs). Minor complications (e.g. vaginal bleeding) associated with the use of Dilapan-S were < 2%, and maternal infectious morbidity was not higher compared to Foley balloon and vaginal PGE (2) or misoprostol. Due to these beneficial properties Dilapan-S might be an ideal option for outpatient cervical ripening, as shown in a recent randomized clinical trial comparing inpatient to outpatient cervical ripening. Furthermore, according to the manufacturers’ product information, Dilapan-S is the only cervical ripening method that is not contraindicated for induction of labor in women with a previous cesarean section. Upcoming guidelines should consider synthetic osmotic cervical dilators as an effective and safe method for cervical ripening/induction of labor acknowledging that more evidence-based data are mandatory, particularly in patients with a previous cesarean section. Georg Thieme Verlag KG 2023-07-07 /pmc/articles/PMC10689108/ /pubmed/38046527 http://dx.doi.org/10.1055/a-2103-8329 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Rath, Werner
Kummer, Julia
Königbauer, Josefine T.
Hellmeyer, Lars
Stelzl, Patrick
Synthetic Osmotic Dilators for Pre-Induction Cervical Ripening – an Evidence-Based Review
title Synthetic Osmotic Dilators for Pre-Induction Cervical Ripening – an Evidence-Based Review
title_full Synthetic Osmotic Dilators for Pre-Induction Cervical Ripening – an Evidence-Based Review
title_fullStr Synthetic Osmotic Dilators for Pre-Induction Cervical Ripening – an Evidence-Based Review
title_full_unstemmed Synthetic Osmotic Dilators for Pre-Induction Cervical Ripening – an Evidence-Based Review
title_short Synthetic Osmotic Dilators for Pre-Induction Cervical Ripening – an Evidence-Based Review
title_sort synthetic osmotic dilators for pre-induction cervical ripening – an evidence-based review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689108/
https://www.ncbi.nlm.nih.gov/pubmed/38046527
http://dx.doi.org/10.1055/a-2103-8329
work_keys_str_mv AT rathwerner syntheticosmoticdilatorsforpreinductioncervicalripeninganevidencebasedreview
AT kummerjulia syntheticosmoticdilatorsforpreinductioncervicalripeninganevidencebasedreview
AT konigbauerjosefinet syntheticosmoticdilatorsforpreinductioncervicalripeninganevidencebasedreview
AT hellmeyerlars syntheticosmoticdilatorsforpreinductioncervicalripeninganevidencebasedreview
AT stelzlpatrick syntheticosmoticdilatorsforpreinductioncervicalripeninganevidencebasedreview